Acrivon Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAcrivon Therapeutics

Acrivon Therapeutics(ACRV)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

Histone-arginine methyltransferase carm1

multiple myeloma

,

myeloid leukemia

,

hypercholesterolemia

,

atherosclerosis

,

plasma cell neoplasms

,

gastrointestinal neoplasms

,

intestinal neoplasms

,

,

b-cell lymphoma

,

hematologic neoplasms

,

non-hodgkin lymphoma

,

bcr-abl positive chronic myelogenous leukemia

,

hodgkin disease

,

,

alzheimer disease

,

myeloid leukemia acute

,

b-cell chronic lymphocytic leukemia

,

follicular lymphoma

,

large b-cell lymphoma diffuse

,

b-cell leukemia

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

healthy volunteers/patients

,

,

,

small cell lung carcinoma

,

colorectal neoplasms

,

chronic hepatitis

,

,

,

squamous cell carcinoma of head and neck

,

myeloid leukemia chronic-phase

,

bronchiolitis obliterans syndrome

,

,

hepatitis b virus

,

,

ovarian neoplasms

,

fallopian tube neoplasms

,

clear cell adenocarcinoma

,

uveal neoplasms

,

cutaneous malignant melanoma

,

,

diabetic neuropathies

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

,

,

depressive disorder

,

,

postherpetic neuralgia

,

interstitial lung diseases

,

common variable immunodeficiency

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

pancreatic neoplasms

,

rectal neoplasms

,

urinary bladder neoplasms

,

head and neck neoplasms

,

squamous cell carcinoma

,

,

,

,

prostatic neoplasms

,

non-small-cell lung carcinoma

,

breast neoplasms

,

chronic hepatitis c

,

diabetes mellitus

,

renal cell carcinoma

,

systemic lupus erythematosus

,

,

,

neoplasm metastasis

,

connective tissue diseases

,

immune system diseases

,

autoimmune diseases

,

venous thrombosis

,

pulmonary embolism

,

,

,

developmental disabilities

,

autism spectrum disorder

,

pervasive child development disorders

,

,

,

type 2 diabetes mellitus

,

rheumatoid arthritis

,

,

,

chronic hepatitis b

,

atrial fibrillation

,

communicable diseases

,

,

systemic scleroderma

,

juvenile arthritis

,

psoriatic arthritis

,

ankylosing spondylitis

,

sjogren's syndrome

,

undifferentiated connective tissue diseases

,

,

,

mixed connective tissue disease

healthy volunteers/patients

,

,

follicular lymphoma

,

large b-cell lymphoma diffuse

,

non-hodgkin lymphoma

,

,

,

type 2 diabetes mellitus

,

breast neoplasms

,

liver neoplasms

,

,

non-small-cell lung carcinoma

,

urologic neoplasms

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

uterine cervical neoplasms

,

diabetes mellitus

,

rheumatoid arthritis

,

kidney diseases

,

kidney transplantation

,

alzheimer disease

,

,

,

hepatocellular carcinoma

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

,

esophageal neoplasms

,

biliary tract neoplasms

,

,

,

brain neoplasms

,

hematologic neoplasms

,

lymphoproliferative disorders

,

neoplasms by histologic type

,

neoplasms by site

,

multiple myeloma

,

plasma cell neoplasms

,

colorectal neoplasms

,

,

disability evaluation

,

cognition disorders

,

,

chronic hepatitis b

,

,

,

chronic hepatitis

,

,

multiple sclerosis

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use